NCT04579094

Brief Summary

Brief summary : Very few studies have evaluated the prevalence of multi-drug resistant (MDR), highly resistant emerging bacteria and Clostridioides difficile toxinogenic (CDt) in residents and in healthcare workers (HCW) in nursing home (NH). Most of study were conducted in acute care services and were limited to specific bacterial species. Hypothesis : The carriage of MDR bacteria in resident may be a risk factor for an outbreak in NH or in healthcare facility. Primary outcome: The objective of this study is to estimate the prevalence for carriage of MDR bacteria and CDt in residents in NH. Secondary outcomes:

  • Estimate the prevalence for carriage of MDR bacteria and CDt toxigenic in HCW in NH.
  • Identify the risk factors for carriage of MDR bacteria and CDt in residents in nursing home
  • Identify the risk factors for carriage of MDR bacteria and CDt in healthcare workers in NH
  • Evaluate the presence of cross-transmission of MDR bacteria and CDt in one or several NH
  • Evaluate the association between the presence of cross-transmission of MDR bacteria and CDt in a NH and the management of infection control
  • Establishment a collection of stool samples

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
492

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 8, 2020

Completed
1.6 years until next milestone

Study Start

First participant enrolled

May 25, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

2.4 years

First QC Date

October 1, 2020

Last Update Submit

May 26, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Presence or absence of multi-drug resistant bacteria in residents' feces.

    prevalence of carriage of multi-drug resistant bacteria

    at inclusion (J0)

  • Presence or absence of Highly Resistant and Emerging Bacteria in residents' feces.

    prevalence of carriage of Highly Resistant and Emerging Bacteria

    at inclusion (J0)

  • Presence or absence of Clostridioids difficult toxinogenic in residents' feces.

    prevalence of carriage of Clostridioids difficult toxinogenic

    at inclusion (J0)

Study Arms (2)

1/elderly dependent persons

Other: Feces sampling at inclusion (J0)

2/healthcare workers (HCW)

Other: Feces sampling at inclusion (J0)

Interventions

Feces sampling at inclusion (J0)

1/elderly dependent persons2/healthcare workers (HCW)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The target population of the study is all elderly residents of nursing home and their caregivers. The source population of the study corresponds to the residents of the 61 nursing home in the Gard region, and their caregivers.

You may qualify if:

  • Resident :
  • The resident must be a member or beneficiary of a health insurance. The resident is in permanent accommodation whose the date of admission is at least 1 month earlier on the day of collection.
  • healthcare workers : The healthcare workers must be a member or beneficiary of a health insurance. The healthcare workers begin to work in nursing at least 1 month earlier on the day of collection.

You may not qualify if:

  • Resident :
  • The resident refuses to participate.
  • o healthcare workers : The healthcare workers refuses to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nîmes, Hôpital Universitaire Carémeau

Nîmes, France

Location

MeSH Terms

Conditions

Cross Infection

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2020

First Posted

October 8, 2020

Study Start

May 25, 2022

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

May 28, 2025

Record last verified: 2025-05

Locations